Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of...
Ionis Pharmaceuticals, Inc., the leader in RNA-targeted therapies, announced the publication of positive Phase 2 data for donidalorsen (formerly IONIS-PKK-LRx) in the New England...
